Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
FDA places Regeneron and Teva's pain-drug study on hold
Tuesday, October 18, 2016Regeneron Pharmaceuticals Inc and partner Teva Pharmaceutical Industries Ltd said the US health regulator placed a clinical hold on a study testing their pain treatment dealing another blow to companies looking to develop a safer alternative to opioi...
Celgene Crohn’s Drug Benefit Supported by Image Data in Trial
Monday, October 17, 2016Celgene Corps experimental pill for Crohns disease helped more patients than analysts expected reinforcing positive results of an earlier study and likely boosting investors confidence in the drugs chances of approval Thirtyseven percent of patients...
Cipla signs deal to set up first biosimilars unit in South Africa
Monday, October 17, 2016Indian pharmaceutical major Cipla has signed a memorandum of agreement for South Africas first biosimilars manufacturing facility to be set up at a cost of nearly million The agreement with KwaZuluNatal Dube Trade Port Special Economic Zone for Cip...
TiGenix Announces Orphan Drug Designation (ODD) for Cx601 in Switzerland
Monday, October 17, 2016TiGenix NV an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platforms of allogeneic expanded stem cells today announced that Cx its lead product candidate being developed for the...
Osiris Therapeutics says commenced steps to terminate enrollment in OTI-15-01 phase III clinical trial
Saturday, October 15, 2016Osiris Therapeutics Inc says on October company commenced steps to terminate enrollment in its OTI phase III clinical trial Osiris trial was investigating safety and efficacy of OTI in patients suffering from chronic DFUS that have not responded t...
EMA committee conditionally approves AbbVie leukemia drug
Saturday, October 15, 2016AbbVie Inc won the conditional backing of an advisory committee of the European Medicines Agency EMA on Friday for a drug to treat a form of blood cancer The tablet venclyxto or venetoclax is aimed at chronic lymphocytic leukemia CLL patients with e...
Lupin, Boehringer Ingelheim India to co-market diabetes drug Empagliflozin
Friday, October 14, 2016Lupin Ltd type diabetes Boehringer Ingelheim India and Lupin announce strategic comarketing agreement Lupin Ltd says will market sell Empagliflozin under separate brand name Gibtulio Lupin Ltd says Boehringer will continue to sell Empagliflozin u...
Pfizer loses appeal in UK patent case over use of Lyrica drug for pain
Friday, October 14, 2016Pfizer suffered a setback in Britain on Thursday when the Court of Appeal in London ruled against it in a patent case over the use of its billionayear drug Lyrica for pain relief Pfizer said it was disappointed by the decision and would seek a furt...
Denmark's Genmab looks to immunotherapy for cancer drug encore
Friday, October 14, 2016Immunotherapy which boosts the immune system to fight cancer could be the next big opportunity for Genmab potentially driving peak sales of its topselling drug well past billion a year its chief executive believes Shares in the Danish firm have sur...
Sun Pharma recalls 31,762 bottles of antidepressant drug in US
Thursday, October 13, 2016Sun Pharmaceutical Industries is recalling bottles of bupropion hydrochloride extended release tablets used for treatment of major depressive disorder in the US due to failed dissolution specifications The recall has been initiated by Sun Pharmaceu...
